Broker Recommendations

Goldman upgrades Rentokil to 'buy', hikes price target

By Michele Maatouk

Date: Tuesday 07 Jul 2026

(Sharecast News) - Goldman Sachs upgraded Rentokil Initial on Tuesday to 'buy' from 'neutral' and lifted the price target to 590p from 515p.
The bank said it believes the organic growth inflection in North America, which started in the third quarter of 2025, is sustainable with a potential to reach mid-single...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page